While symptoms of ALS progress over time, there may be key signs of this condition in its early phases. Some of these early signs may differ slightly in females with ALS. It’s especially ...

Researchers have uncovered a mechanism that may trigger ALS’s earliest stages, identifying proteins that mislocalize, causing ...

Approximately 5,000 people in the U.S. develop amyotrophic lateral sclerosis (ALS) each year. On average, they survive for ...

Discover the surprising link between head-shaking and concussion symptoms. Learn how this instinctive motion can indicate a ...

New hope could be on the horizon for ALS patients in the form of a "breakthrough" drug, researchers say. Neuvivo, a California biopharmaceutical company that develops therapies for ...

The ALS Association joined the Coca-Cola Southwest Beverages Porch to share details about the Walk to Defeat ALS in Oklahoma ...

Cranium Detect AI deeply understands an enterprise-scale codebase, unlike standard code analysis tools. The tool uses state-of-the-art Al and deterministic logic to scan and uncover the presence ...

Approximately 5,000 people in the U.S. develop amyotrophic lateral sclerosis (ALS) each year. On average, they survive for only two to five years after being diagnosed, according to the Centers for ...

Diagnosed with amyotrophic lateral sclerosis (ALS), the disease not only affected Kerner's mobility but also her ability to speak. However, thanks to artificial intelligence technology ...

NeuroSense Therapeutics Ltd., a late-clinical stage biotechnology company developing novel treatments for severe neurodegenerative diseases – such as amyotrophic lateral sclerosis (ALS), Alzheimer’s ...